国产成人精品在线免费,在线久艹视频精品,歐美日韩视频

FDA Approves Lazertinib and Amivantamab for First-Line NSCLC Treatment FDA The FDA has approved lazertinib (Lazcluze) and amivantamab-vmjw (Rybrevant) for the first-line treatment of advanced non-small cell lung cancer (NSCLC) with specific EGFR mutations. The combination therapy showed significant improvement in progression-free survival in the MARIPOSA trial.
FDA Approves Kisunla for Alzheimer’s Treatment FDA Discover how Kisunla (donanemab-azbt) injection, FDA-approved for Alzheimer’s treatment, reduces cognitive decline in adults with mild impairment or dementia.
SKYRIZI? Approved for Ulcerative Colitis Treatment by FDA Abbvie SKYRIZI? (risankizumab-rzaa) approval by the FDA marks a milestone in treating ulcerative colitis and Crohn's disease, highlighting clinical trials, impact on patients, and safety considerations.
FDA Approves Repotrectinib (Augtyro) for NTRK FDA The FDA granted accelerated approval to repotrectinib (Augtyro) for adults and children aged 12+ with NTRK fusion-positive tumors. The TRIDENT-1 trial showed a 58% ORR in TKI-na?ve patients and a 50% ORR in TKI-pretreated patients, highlighting its efficacy and potential.
FDA Approves Imetelstat for Low- to Intermediate-1 Risk MDS FDA On June 6, 2024, the FDA approved imetelstat (Rytelo) for adults with low- to intermediate-1 risk myelodysplastic syndromes (MDS) and transfusion-dependent anemia. The approval is based on significant trial results demonstrating RBC transfusion independence.
Ensuring Pharmaceutical Quality: CDER's Comprehensive Approach FDA CDER ensures pharmaceutical quality by monitoring manufacturing facilities and conducting risk-based inspections to guarantee the safety and effectiveness of medications.
Raw Milk from H5N1-Infected Cows Poses Risks NIH Consuming raw milk from H5N1-infected cows poses significant infection risks. Learn about virus levels, pasteurization effectiveness, and public health concerns.
FDA Approves Bkemv as First Interchangeable Biosimilar to Soliris FDA FDA approves Bkemv (eculizumab-aeeb), the first interchangeable biosimilar to Soliris, for treating rare diseases like PNH and aHUS, enhancing treatment access.
FDA Approves Biosimilars Yesafili and Opuviz FDA FDA approves Yesafili and Opuviz as interchangeable biosimilars to Eylea, offering new treatments for wet AMD, macular edema, and diabetic retinopathy.
FDA Approves First Drug for Wild Quail Treatment" FDA Discover the FDA's first-ever approval of Safe-Guard (fenbendazole) for treating gastrointestinal worms in wild quail, a breakthrough for wildlife management.

< Pre 1...5 6 789 10 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水